OWD
BAK icon

Osborn Williams & Donohoe’s Braskem BAK Stock Holding History

Osborn Williams & Donohoe’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-700
Closed -$18K – 347
2019
Q1 		$18K Buy
+700
New +$19.4K ﹤0.01% 569

Other funds holding BAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
DTL
Dynamic Technology Lab Singapore $615M AUM 11.3% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Osborn Williams & Donohoe's BAK Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Braskem (BAK) in Q2 2019, closing a stake of 700 shares — an estimated $18K sold.

Osborn Williams & Donohoe first reported a position in BAK in Q1 2019 and held it in 1 quarter. The position peaked at $18K in Q1 2019. 17 funds tracked by Wall St. Rank hold BAK as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Braskem position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 700 Braskem shares in Q2 2019, an estimated $18K.
  • Osborn Williams & Donohoe first reported a position in Braskem in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Braskem position peaked at $18K in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Braskem as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.